Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Hal Barron
Recent news which mentions Hal Barron
Lilly jumps in with Vir, GSK on antibody drug combo against Covid
January 27, 2021
Tags
Eli Lilly and Company
Insurance
Pharmaceuticals
From
Business Journals
GlaxoSmithKline, Vir Biotechnology begin late-stage testing of experimental Covid-19 therapy
August 31, 2020
Tags
Insurance
Pharmaceuticals
Coronavirus
From
Business Journals
GlaxoSmithKline granted FDA approval for drug to treat multiple myeloma
August 06, 2020
Tags
Health Care
Insurance
GlaxoSmithKline
From
Business Journals
In quest to beat COVID-19, Bay Area biotech closes Big Pharma equity deal for $250M
April 06, 2020
Tags
Pharmaceuticals
George Scangos
Insurance
From
Business Journals
GlaxoSmithKline teams with Vir Biotechnology to develop coronavirus vaccine, treatments
April 06, 2020
Tags
Hal Barron
Coronavirus
GlaxoSmithKline
From
Business Journals
Longtime Genentech exec retiring as new CEO settles in
August 19, 2019
Tags
Pharmaceuticals
Calico Life Sciences
Eli Lilly and Company
From
Business Journals
GSK layoffs focused on PA and U.K. sites – not Triangle
April 19, 2019
Tags
Insurance
Jeff Blumenthal
Health Care
From
Business Journals
GSK cuts employees at its R&D unit in Collegeville
April 19, 2019
Tags
Hal Barron
GlaxoSmithKline PLC
Health Care
From
Business Journals
$4.2B deal: GSK and Merck KGaA to develop cancer immunotherapy
February 05, 2019
Tags
Health Care
GlaxoSmithKline PLC
Hal Barron
From
Business Journals
Federal shutdown cancels conference aimed at health care cooperation
January 04, 2019
Tags
Laura Esserman
Anne Wojcicki
Mitch McConnell
From
Business Journals
Waltham's Tesaro to be acquired by GlaxoSmithKline for $5.1B
December 03, 2018
Tags
GlaxoSmithKline PLC
Bioscience
Health Care
From
Business Journals
$5.1B deal: GSK to buy Boston-area cancer drug developer
December 03, 2018
Tickers
GSK
Tags
Emma Walmsley
TESARO, Inc/
Mergers and Acquisitions
From
Business Journals
23andMe gets $300M investment from GlaxoSmithKline
July 25, 2018
Tickers
GSK
Tags
Anne Wojcicki
GSK
New Enterprise Associates
From
Business Journals
$300M DNA play: GSK to collaborate with 23andMe on genetics-driven drug discovery
July 25, 2018
Tickers
GSK
Tags
Health Care
Hal Barron
Emma Walmsley
From
Business Journals
Why AdaptImmune collected $27.5M from GSK
July 24, 2018
Tickers
GSK
Tags
Pharmaceuticals
GSK
Adaptimmune LLC (Philadelphia, PA)
From
Business Journals
GlaxoSmithKline R&D leader departing for UK government job
November 08, 2017
Tickers
GSK
Tags
Hal Barron
Emma Walmsley
GSK
From
Business Journals
Genentech R&D chief Richard Scheller to retire
December 12, 2014
Tickers
PFE
Tags
Early Development
Stanford University
Art Levinson
From
Business Journals
Art Levinson's Google-backed aging research company Calico is hiring
December 01, 2014
Tickers
ABBV
Tags
Robert Cohen
Art Levinson
Calico
From
Business Journals
Google's Calico inks deal around neurodegenerative diseases
September 11, 2014
Tickers
ABBV
Tags
Claria Bioscience
Calico
Art Levinson
From
Business Journals
Calico, AbbVie look at $1.5 billion partnership on age-related diseases
September 03, 2014
Tickers
ABBV
ABT
JOBS
Tags
Banking & Financial Services
Pharmaceuticals
Abbott Laboratories
From
Business Journals
Stanford researchers hope plasma injections from the young will rejuvenate Alzheimer's patients
May 05, 2014
Tags
Saul Villeda
Health Care
UC Berkeley
From
Business Journals
Young blood: Stanford researchers hope plasma injections from the young rejuvenate Alzheimer's patients
May 04, 2014
Tags
Stanford University
Art Levinson
Innovation
From
Business Journals
Hal Barron of Google-backed aging research company Calico: 'We can do better'
December 10, 2013
Tags
Innovation
Technology
Art Levinson
From
Business Journals
Genentech scores FDA approval for new leukemia drug
November 01, 2013
Tickers
RHHVF
Tags
Hal Barron
Biotech
Health Care
From
Business Journals
Genentech's Perjeta wins FDA OK with new approach to breast cancer
September 30, 2013
Tickers
RHHVF
Tags
Genentech Inc/
Roche
Pharmaceuticals
From
Business Journals
Genentech leukemia drug passes big test vs. blockbuster Rituxan
July 23, 2013
Tickers
RHHVF
Tags
Hal Barron
Biotech
Health Care
From
Business Journals
Genentech eyes Dec. 20 FDA decision date for new leukemia drug
July 03, 2013
Tickers
RHHVF
Tags
Biotech
Hal Barron
Health Care
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.